In an article be exposed in the March issue of the Journal of fitness Pharmacology and Therapeutics, researchers from Florida south pacific ocean health center (FAU) assess the totality of evidence, including strengths and limitations of different types of index contributing to the debate about physical conditioning disease (CVD) risks of cyclooxygenase-2 (COX-2) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs).

More: - The rest...